PharmaShots | Incisive News in 3 Shots

Subscribe Now

Target

Immunai Acquire Dropprint Genomics to Expand its Target Discovery Capabilities

Immunai Acquire Dropprint Genomics to Expand its Target Discovery Capabilities

March 26, 2021

Evotec Collaborates with Rappta Therapeutics to Focus on Oncology Target

Evotec Collaborates with Rappta Therapeutics to Focus on Oncology Target

November 25, 2020

Takeda Collaborates with Engitix to Target Fibrotic Liver Diseases

Takeda Collaborates with Engitix to Target Fibrotic Liver Diseases

August 26, 2020

Evotec and Centogene Expand their Collaboration to Target Gaucher Disease

Evotec and Centogene Expand their Collaboration to Target Gaucher Disease

August 20, 2020

Vir and Alnylam Expand their 2017 License Agreement to Target COVID-19

Vir and Alnylam Expand their 2017 License Agreement to Target COVID-19

March 5, 2020

Bayer Signs a Three Year Multi Target AI-based Agreement with Exscientia to Treat Cardiovascular and Oncology Diseases

Bayer Signs a Three Year Multi Target AI-based Agreement with Exscientia to Treat Cardiovascular and Oncology Diseases

January 10, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us